Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS) by Knox Andrew, Schneider Andrea, Abucayan Floridette, Hervey Crystal, Tran Christina, Hessl David, Berry-Kravis Elizabeth

Get full text

Arbaclofen in fragile X syndrome: results of phase 3 trials by Berry-Kravis, Elizabeth, Hagerman, Randi, Visootsak, Jeannie, Budimirovic, Dejan, Kaufmann, Walter E., Cherubini, Maryann, Zarevics, Peter, Walton-Bowen, Karen, Wang, Paul, Bear, Mark, Carpenter, Randall L

Get full text
Get full text

Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial by Berry-Kravis, Elizabeth M., Hessl, David, Rathmell, Barbara, Zarevics, Peter, Cherubini, Maryann, Walton-Bowen, Karen, Mu, Yi, Nguyen, Danh V., Gonzalez-Heydrich, Joseph, Wang, Paul P., Carpenter, Randall L., Hagerman, Randi J., Bear, Mark

Get full text

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome by Berry-Kravis, Elizabeth M., Lindemann, Lothar, Jønch, Aia E., Apostol, George, Bear, Mark, Carpenter, Randall L, Crawley, Jacqueline N., Curie, Aurore, Des Portes, Vincent, Hossain, Farah, Gasparini, Fabrizio, Gomez-Mancilla, Baltazar, Hessl, David, Loth, Eva, Scharf, Sebastian H., Wang, Paul P., Von Raison, Florian, Hagerman, Randi, Spooren, Will, Jacquemont, Sébastien

Get full text